Source: British Journal of Pharmacology. Unidades: FMRP, FORP
Subjects: ESTRESSE OXIDATIVO, METALOPROTEINASES, HIPERTENSÃO (TRATAMENTO)
ABNT
CERON, C. S. et al. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. British Journal of Pharmacology, v. 160, n. 1, p. 77-87, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1476-5381.2010.00678.x. Acesso em: 03 set. 2024.APA
Ceron, C. S., Castro, M. M., Rizzi, E., Montenegro, M. F., Fontana, V., Salgado, M. C. de O., et al. (2010). Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. British Journal of Pharmacology, 160( 1), 77-87. doi:10.1111/j.1476-5381.2010.00678.xNLM
Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC de O, Gerlach RF, Tanus-Santos JE. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension [Internet]. British Journal of Pharmacology. 2010 ; 160( 1): 77-87.[citado 2024 set. 03 ] Available from: https://doi.org/10.1111/j.1476-5381.2010.00678.xVancouver
Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC de O, Gerlach RF, Tanus-Santos JE. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension [Internet]. British Journal of Pharmacology. 2010 ; 160( 1): 77-87.[citado 2024 set. 03 ] Available from: https://doi.org/10.1111/j.1476-5381.2010.00678.x